Background. Previous studies to determine the significant donor and ho
st factors which contribute to immune responses to allogeneic hepatocy
tes have been pursued with in vitro and in vivo studies. However, in o
rder to further characterize in vivo host immune responses to transpla
nted hepatocytes in conjunction with their consequences upon allograft
survival, a functional model of hepatocyte transplantation in which t
he function and survival of transplanted hepatocytes could be serially
assessed was pursued, Methods. A transgenic mouse line expressing the
human alpha(1)-antitrypsin (hA1AT) gene was developed in an FVB/N (H2
(q)) mouse (hA1AT-FVB/N), Hepatocytes from these ''donor'' transgenic
mice were transplanted into host mice by intrasplenic injection, and s
ubsequent survival of the transgenic hepatocytes was determined by ass
ay for the secreted hA1AT protein in host serum by enzyme-linked immun
osorbent assay, Results. Transplantation of transgenic ''donor'' hepat
ocytes (hA1AT-FVB/N) into (a) syngeneic FVB/N (H2(q)), (b) allogeneic
immunoincompetent C57BL/6.SCID (H2(b)), or (c) allogeneic T cell-defic
ient (outbred) hosts resulted in long-term survival (>16 weeks) of hep
atocytes. Transplantation of allogeneic hepatocytes (hA1AT-FVB/N, H2(q
)) into C57BL/6 (H2(b)), C3H (H2(k)), or BALB/c (H2(d)) hosts resulted
in loss of hA1AT in host serum by day 10 after transplant. Likewise,
transplantation of allogeneic hepatocytes into hosts deficient in B ce
lls, CD8(+) T cells, or CD4(+) T cells resulted in loss of hA1AT by da
y 10 after transplant, Conclusions. This functional model of hepatocyt
e transplantation is validated for the study of host immune responses
to hepatocellular grafts and to assess efficacy of strategies designed
to alter these in vivo immune responses, The immunologic rejection of
allogeneic hepatocytes appears to be T cell-mediated.